CD93 and acute myeloid leukemia: Petersen et al. likewise confirmed increased expression of CD123, as well as CLL and IL1RAP, in primitive populations from AML patients versus healthy bone marrow donors, but noted that IL1RAP, CD93, and CD25 expression was not restricted to populations harboring AML-associated genetic mutations [58].